How much funding has Junction Bioscience raised?

Junction Bioscience has raised $500K in total funding, most recently a Convertible Note round.

Who are Junction Bioscience's investors?

Junction Bioscience's investors include Y Combinator Continuity Fund.

When was Junction Bioscience founded?

Junction Bioscience was founded in 2024.

What industry is Junction Bioscience in?

Junction Bioscience operates in Artificial Intelligence, Biotech, Drug Discovery, Healthcare, Therapeutics.

How many employees does Junction Bioscience have?

Junction Bioscience has 1-10 employees.

Junction Bioscience

AI Hypothesis Engine for Molecular Discovery

Founded 2024 · $500K raised

Artificial Intelligence

YC W24

Employees: 1–10
Founded: 2024
Website: junction.bio

Total Funding: $500K
Last Round: $500K Convertible NoteJan 2024
Rounds: 1

About

Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control over the molecular basis of disease. We focus on the intersection of neuroinflammation and immunology where uncommon molecular insights position us to develop best-in-class therapies for millions of patients in need.

Summary

Junction Bioscience is an Artificial Intelligence company, founded in 2024. It has raised $500K in total across 1 round, most recently a $500K Convertible Note round in Jan 2024. Investors include Y Combinator Continuity Fund.